The diagnostic value of cognitive assessment indicators for mild cognitive impairment (MCI)

被引:0
作者
Han, Keyan [1 ,2 ,3 ,4 ,5 ]
Liang, Wei [1 ,2 ,3 ,4 ,5 ]
Geng, Hao [1 ,2 ,3 ,4 ,5 ]
Jing, Xinyang [1 ,2 ,3 ,4 ,5 ]
Wang, Xuemeng [1 ,2 ,3 ,4 ,5 ]
Huo, Yaxin [1 ,2 ,3 ,4 ,5 ]
Li, Wei [1 ,2 ,3 ,4 ,5 ]
Huang, Anqi [1 ,2 ,3 ,4 ,5 ]
An, Cuixia [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] First Hosp Hebei Med Univ, Dept Psychiat, Shijiazhuang, Peoples R China
[2] Hebei Clin Res Ctr Mental Disorders, Shijiazhuang, Peoples R China
[3] Inst Mental Hlth, Shijiazhuang, Peoples R China
[4] Hebei Med Univ, Mental Hlth Ctr, Shijiazhuang, Peoples R China
[5] Hebei Tech Innovat Ctr Mental Hlth Assessment & In, Shijiazhuang, Peoples R China
[6] First Hosp Hebei Med Univ, Dept Psychiat, 89 Donggang Rd, Shijiazhuang 050031, Hebei, Peoples R China
基金
美国国家科学基金会;
关键词
Dementia; diagnosis; ELISA; mild cognitive impairment; Mini-Mental State Examination; Montreal Cognitive Assessment; Sniffing test; MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; DEMENTIA;
D O I
10.1080/23279095.2024.2306144
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study aims to evaluate and analyze the standard diagnostic methods for mild cognitive impairment (MCI). Methods: This study used a prospective case-control study to examine baseline data and diagnostic indicators in a population of elderly with MCI. Based on different cognitive abilities, this study divided MCI and healthy control groups. The diagnostic indicators included CDT, MOCA, MMSE, PSQI, MBI, DST, HAMD, AD-related blood markers, and olfactory testing. The diagnostic value of each indicator was done using the ROC curve. Results: This study included 240 adult participants, 135 in the health group and 105 in the MCI group. A comparison of baseline data revealed statistically significant differences between the two groups regarding age, blood glucose, MMSE, CTD, MOCA, ability to perform daily living, AD-related blood indices and olfactory tests (all p < 0.05). Logistic regression analysis statistically showed that age, MOCA, and CDT were independent diagnostic factors for MCI (all p < 0.05). Combining these three indicators has the best diagnostic specificity (92.54%). AD-related blood and olfactory tests indices had only moderate diagnostic values (AUC: 0.7-0.8). Conclusion: Age, MOCA, and CDT are good indicators for diagnosing early-stage MCI. AD-related blood indices and olfactory tests can serve as valuable adjuncts in diagnosing MCI.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Working Memory, Vocabulary Breadth and Depth in Reading Comprehension: A Study with Third Graders
    Artuso, Caterina
    Palladino, Paola
    [J]. DISCOURSE PROCESSES, 2022, 59 (09) : 685 - 701
  • [2] New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
    Chiu, M. J.
    Yang, S. Y.
    Chen, T. F.
    Chieh, J. J.
    Huang, T. Z.
    Yip, P. K.
    Yang, H. C.
    Cheng, T. W.
    Chen, Y. F.
    Hua, M. S.
    Horng, H. E.
    [J]. CURRENT ALZHEIMER RESEARCH, 2012, 9 (10) : 1142 - 1148
  • [3] Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis
    Ciesielska, Natalia
    Sokolowski, Remigiusz
    Mazur, Ewelina
    Podhorecka, Marta
    Polak-Szabela, Anna
    Kedziora-Kornatowska, Kornelia
    [J]. PSYCHIATRIA POLSKA, 2016, 50 (05) : 1039 - 1052
  • [4] Apathy and depression in amnestic and non-amnestic mild cognitive impairment
    D'Iorio, Alfonsina
    Santangelo, Gabriella
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2022, 44 (02) : 103 - 108
  • [5] Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia
    Davis, Matthew
    O'Connell, Thomas
    Johnson, Scott
    Cline, Stephanie
    Merikle, Elizabeth
    Martenyi, Ferenc
    Simpson, Kit
    [J]. CURRENT ALZHEIMER RESEARCH, 2018, 15 (08) : 777 - 788
  • [6] Repetition Priming in Individuals with Amnestic Mild Cognitive Impairment and Alzheimer's Dementia: a Systematic Review and Meta-Analysis
    De Wit, Liselotte
    Piai, Vitoria
    Thangwaritorn, Pilar
    Johnson, Brynn
    O'Shea, Deirdre
    Amofa, Priscilla, Sr.
    Marsiskel, Michael
    Kessels, Roy P. C.
    Schaefer, Nancy
    Smith, Glenn
    [J]. NEUROPSYCHOLOGY REVIEW, 2022, 32 (02) : 228 - 246
  • [7] Clock-drawing test in vascular mild cognitive impairment: Validity of quantitative and qualitative analyses
    Dong, Fangming
    Shao, Kai
    Guo, Shangzun
    Wang, Wei
    Yang, Yiming
    Zhao, Zhongmin
    Feng, Rongfang
    Wang, Jianhua
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2020, 42 (06) : 622 - 633
  • [8] ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE 2016 (AAIC 2016)
    Dulsat, C.
    [J]. DRUGS OF THE FUTURE, 2016, 41 (08) : 525 - 530
  • [9] 2022 Alzheimer's disease facts and figures
    Gaugler, Joseph
    James, Bryan
    Johnson, Tricia
    Reimer, Jessica
    Solis, Michele
    Weuve, Jennifer
    Buckley, Rachel F.
    Hohman, Timothy J.
    [J]. ALZHEIMERS & DEMENTIA, 2022, 18 (04) : 700 - 789
  • [10] The Value of Clock Drawing Process Assessment in Screening for Mild Cognitive Impairment and Alzheimer's Dementia
    Huang, Yanlu
    Pan, Feng-Feng
    Huang, Lin
    Guo, Qihao
    [J]. ASSESSMENT, 2023, 30 (02) : 364 - 374